![](/sites/default/files/default_images/transgender_1.png)
SERAFINI MARTA
Publications
Castiello, M., Brandas, C., Ferrari, S., Porcellini, S., Sacchetti, N., Canarutto, D., et al. (2024). Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency. SCIENCE TRANSLATIONAL MEDICINE, 16(733) [10.1126/scitranslmed.adh8162]. Detail
Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD [10.1182/blood.2023021349]. Detail
Donsante, S., Pievani, A., Palmisano, B., Finamore, M., Fazio, G., Corsi, A., et al. (2024). Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells. JCI INSIGHT, 9(5) [10.1172/jci.insight.173449]. Detail
Pievani, A., Biondi, M., Tettamanti, S., Biondi, A., Dotti, G., Serafini, M. (2024). CARs are sharpening their weapons. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 12(1) [10.1136/jitc-2023-008275]. Detail
Arsuffi, C., Biondi, A., Tettamanti, S., Serafini, M. (2023). Acute Myeloid Leukemia (AML) immunotherapy: development of TIM3-CD33 targeted Dual CAR CIK cells for eradication of LSCs in the bone marrow niche. Intervento presentato a: Giornata Dottorati Medicina, Monza. Detail
Awards
Research and teaching assignments
- Attivita' di insegnamento - Università degli Studi di MILANO-BICOCCA, 2020 - 2021